Spinocerebellar degeneration, ataxic gait, and speech impairment are among the progressive neurologic impairments that some gamma-glutamylcysteine synthetase deficiency patients may have [1,2,3,4,5,6]. The gene discussed is GCLC; the disease is hyperinsulinemic hypoglycemia, familial, 4.